InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Monday, 05/20/2013 12:48:31 PM

Monday, May 20, 2013 12:48:31 PM

Post# of 261
Peregrines "Bavituximab" now headed to Phase III ... PD-1, PD-L1... vs. Bavituximab -- already inching towards the goal line

http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=765925

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RHHBY News